Écrit par GlobalData | 28 Janvier 2019

Following the UK government’s announcement (Thursday 24 January) that the National Institute for Health and Clinical Excellence (NICE) and NHS England will trial a value-based pricing model for antibiotics to help stimulate R&D and address growing antimicrobial resistance (AMR) concerns,

Christopher J. Pace, Director of Infectious Diseases at GlobalData, a leading data and analytics company...

Écrit par GlobalData | 28 Janvier 2019

Biogen’s recent deal announcement with C4 Therapeutics and Skyhawk Therapeutics will be crucial for Biogen to advance their position in the neuroscience portfolio, particularly in embracing innovative strategies to tackle neurology diseases, says GlobalData, a leading data and analytics company.

The partnership with the two companies enables Biogen to plug into new market opportunities with...

Écrit par GLobal Data | 24 Janvier 2019

A study funded by the Medical Research Council, British Heart Foundation and the National Institutes of Health has revealed that an ultrasound scan of blood vessels in the neck has the potential to help doctors predict whether patients have an increased likelihood of developing vascular dementia later in life.

Magdalene Crabbe, Pharma Analyst at GlobalData, a leading data and analytics...

Écrit par A-Mansia Biotech | 20 Janvier 2019

A-Mansia Biotech, active dans le domaine du microbiome, annonce la nomination de Cees de Jong à la présidence de son Conseil d’Administration. Son expérience de gestion réussie de plusieurs entreprises de renommée internationale dans les sciences de la vie renforce A-Mansia dans son ambition de lancer de nouveaux produits dans le domaine du métabolisme.

Passionné par la santé...